Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Lacher MD"'
Autor:
Wiseman CL; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA., Holmes JP; Hematology Oncology, Providence Medical Group Santa Rosa - Cancer Center, Santa Rosa, CA, USA., Calfa C; Medical Oncology, University of Miami, Miami, FL, USA., Dakhil SR; Medical Oncology, Cancer Center of Kansas, Wichita, KS, USA., Bhattacharya S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Peoples GE; Oncology, Lumabridge, San Antonio, TX, USA., Lacher MD; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA., Lopez-Lago M; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA., Kharazi A; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA.; Discovery, Stemedica Cell Technologies, Inc, San Diego, USA., Del Priore G; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA.; Obstetrics & Gynecology, Morehouse School of Medicine, Atlanta, GA, USA., Chang M; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA., Adams DL; Discovery, Creatv MicroTech, Inc., Rockville, MD, USA., Williams WV; Development, BriaCell Therapeutics Corp, Philadelphia, PA, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2379864. Date of Electronic Publication: 2024 Aug 20.
Autor:
Stieglitz E; University of California San Francisco, Benioff Children's Hospital, San Francisco, CA., Gu CJ; Notable Labs, Foster City, CA., Richardson M; Notable Labs, Foster City, CA., Kita R; Notable Labs, Foster City, CA., Santaguida MT; Notable Labs, Foster City, CA., Ali KA; Notable Labs, Foster City, CA., Strachan DC; Notable Labs, Foster City, CA., Dhar A; Notable Labs, Foster City, CA., Yam G; Notable Labs, Foster City, CA., Anderson W; Notable Labs, Foster City, CA., Anderson E; Notable Labs, Foster City, CA., Hübner J; University of California San Francisco, Benioff Children's Hospital, San Francisco, CA., Tasian SK; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research and University of Pennsylvania School of Medicine, Philadelphia, PA., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA., Lacher MD; Notable Labs, Foster City, CA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300302.
Autor:
Wiseman CL; BriaCell Therapeutics Corporation, 2929 Arch Street, 3rd Floor, Philadelphia, PA, 19104, USA., Kharazi A; Immunotherapy Laboratory, St. Vincent Medical Center, Los Angeles, CA, USA., Sunkari VG; BriaCell Therapeutics Corporation, 2929 Arch Street, 3rd Floor, Philadelphia, PA, 19104, USA., Galeas JL; BriaCell Therapeutics Corporation, 2929 Arch Street, 3rd Floor, Philadelphia, PA, 19104, USA., Dozio V; Operations Department, Biognosys AG, Wagistrasse 21, 8952, Schlieren, Switzerland., Hashwah H; Sales and Marketing Nebion AG, Hohlstrasse 515, 8048, Zurich, Switzerland., Macúchová E; Sales and Marketing Nebion AG, Hohlstrasse 515, 8048, Zurich, Switzerland., Williams WV; BriaCell Therapeutics Corporation, 2929 Arch Street, 3rd Floor, Philadelphia, PA, 19104, USA., Lacher MD; BriaCell Therapeutics Corporation, 2929 Arch Street, 3rd Floor, Philadelphia, PA, 19104, USA.
Publikováno v:
Recent patents on anti-cancer drug discovery [Recent Pat Anticancer Drug Discov] 2022; Vol. 18 (2), pp. 224-240.
Autor:
Wang, Yanmeng1 (AUTHOR), Vandewalle, Niels1 (AUTHOR), De Veirman, Kim1,2 (AUTHOR), Vanderkerken, Karin1 (AUTHOR), Menu, Eline1 (AUTHOR) Eline.Menu@vub.be, De Bruyne, Elke1 (AUTHOR) Elke.De.Bruyne@vub.be
Publikováno v:
Cell Communication & Signaling. 6/11/2024, Vol. 22 Issue 1, p1-17. 17p.
Autor:
Lacher MD; BriaCell Therapeutics Corp., Berkeley, CA, United States., Bauer G; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Fury B; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Graeve S; BriaCell Therapeutics Corp., Berkeley, CA, United States., Fledderman EL; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Petrie TD; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Coleal-Bergum DP; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Hackett T; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Perotti NH; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States., Kong YY; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States., Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States., Wagner JP; BriaCell Therapeutics Corp., Berkeley, CA, United States., Wiseman CL; BriaCell Therapeutics Corp., Berkeley, CA, United States., Williams WV; BriaCell Therapeutics Corp., Berkeley, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 May 15; Vol. 9, pp. 776. Date of Electronic Publication: 2018 May 15 (Print Publication: 2018).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Immunology; 2024, p01-15, 15p